Dr Marie Fallon comments on trials of a new pharmaceutical for patients with advanced cancer

Press/Media: Expert Comment

Period8 Jan 2015

Media coverage

2

Media coverage

  • TitleGW Pharmaceuticals and Otsuka announce results in first of three Sativex(R) phase 3 cancer pain trials
    Degree of recognitionInternational
    Media name/outletGlobeNewswire
    Date8/01/15
    PersonsMarie Fallon
  • TitleGW-Otsuka cannabinoid cancer pain candidate fails first of 3 phase III trials
    Degree of recognitionInternational
    Media name/outletGenetic Engineering and Biotechnology News
    Date8/01/15
    PersonsMarie Fallon